ALMAC Pharma Services is a finished-dose manufacturer based in United Kingdom. It appears in 17 regulatory filings across 5 regulators, without an active US DMF or CEP on file. Its filings concentrate with EDE (AE), INVIMA (CO) and ARCSA (EC). Its GMP standing is certified by ANVISA (Brazil), MHRA (UK) and US FDA, among 5 authorities. Its most recent recorded inspection, by US FDA, closed on 28 November 2025 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Dundalk, United Arab Emirates | Not on file |
| Craigavon, United Arab Emirates | Not on file |
| BT635UA, United Arab Emirates | Not on file |
| CRAIGAVON, United Kingdom | Not on file |
| LOUGHBOROUGH, United Kingdom | Not on file |
| NORTHERN IRELAND, United Kingdom | Not on file |
6 further sites are on record.
| Regulator | Filings | GMP certificates |
|---|---|---|
| EDE (AE) | 7 | None |
| INVIMA (CO) | 4 | None |
| ARCSA (EC) | 3 | None |
| MINSA (CR) | 2 | None |
| NAFDAC (NG) | 1 | 1 |
| ANVISA (Brazil) | None | 22 |
| MHRA (UK) | None | 10 |
| US FDA | None | 3 |
| NCELS (KZ) | None | 1 |
Choose your molecules and target markets. ALMAC Pharma Services comes back tiered against every other supplier able to file there.
Start for free